ssl4.eir-parts.net/doc/2160/tdnet/2720910/00.pdf

Latest saved version

2025年12月期 第３四半期決算短信〔ＩＦＲＳ〕（連結）

This is the newest public snapshot for this URL and the best place to start reviewing the page.

Source URL

https://ssl4.eir-parts.net/doc/2160/tdnet/2720910/00.pdf

About this page

This document is the consolidated financial results report for the third quarter of the fiscal year ending December 2025, published by GNI Group, Inc. on November 14, 2025. The report indicates that revenue reached 19,357 million yen, a 12.6% increase compared to the same quarter last year, although the company recorded an operating loss of 497 million yen. The pre-tax profit was a loss of 1,084 million yen, and the quarterly profit was a loss of 2,076 million yen. Total assets amounted to 82,597 million yen, with total equity at 52,531 million yen, and the equity attributable to the parent company was 60.6%. Despite the uncertain economic environment, the company's pharmaceutical and medical device sectors showed stable sales.